When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARVN - Arvinas announces updated ARV-110 phase 1 data for refractory prostate cancer
Arvinas Inc.
Arvinas (NASDAQ:ARVN) down 28.9% post market, after the company announces updated safety and initial efficacy data from the dose escalation portion of its Phase 1/2 clinical trial of ARV-110.
More news on: Arvinas, Inc., Healthcare stocks news,